Azelby Robert has filed 9 insider transactions across 3 companies since March 2024.
Most recent transaction: a grant/award of 1697 shares of Terns Pharmaceuticals, Inc. ($TERN) on February 01, 2026.
Activity breakdown: 0 open-market purchases and 1 sale.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 1, 2026 | Terns Pharmaceuticals, Inc. | $TERN | Azelby Robert | Not found | A | Stock Option (Right to Buy) | 1697 | $0.00 | 1,697.0000 | 91,701,529 | 9999.99% | 0.00% |
| Nov. 5, 2025 | CARDINAL HEALTH INC | $CAH | Azelby Robert | Director | A | Common Shares | 1067 | $0.00 | 4,085.0000 | 239,000,000 | 35.35% | 0.00% |
| June 13, 2025 | ADC Therapeutics SA | $ADCT | Azelby Robert | Director | F | Common Shares | 12600 | $3.58 | 80,405.0000 | 97,159,966 | 13.55% | 0.01% |
| June 3, 2025 | ADC Therapeutics SA | $ADCT | Azelby Robert | Director | A | Common Shares | 40000 | $0.00 | 93,005.0000 | 97,159,966 | 75.46% | 0.04% |
| Feb. 20, 2025 | Terns Pharmaceuticals, Inc. | $TERN | Azelby Robert | Not found | A | Stock Option (Right to Buy) | 90000 | $0.00 | 90,000.0000 | 79,507,474 | 9999.99% | 0.11% |
| Nov. 6, 2024 | CARDINAL HEALTH INC | $CAH | Azelby Robert | Director | A | Common Shares | 1730 | $0.00 | 3,018.0000 | 245,000,000 | 134.32% | 0.00% |
| June 17, 2024 | ADC Therapeutics SA | $ADCT | Azelby Robert | Director | S | Common Shares | 6995 | $2.89 | 53,005.0000 | 81,712,166 | 11.66% | 0.01% |
| June 13, 2024 | ADC Therapeutics SA | $ADCT | Azelby Robert | Director | A | Common Shares | 40000 | $0.00 | 60,000.0000 | 81,712,166 | 200.00% | 0.05% |
| March 15, 2024 | CARDINAL HEALTH INC | $CAH | Azelby Robert | Director | A | Common Shares | 1288 | $0.00 | 1,288.0000 | 262,000,000 | 9999.99% | 0.00% |